Form 4 for MRNA Moderna
Accepted 2026-09-03 16:52:57 ET · period of report 2026-09-01 · accession 0001682852-26-000165 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-03 16:52 | 2026-09-01 | MRNA | Mock James M | CFO | M - OptEx | — | +2,475 | 69.5K | +4% | — |
| D | 2026-09-03 16:52 | 2026-09-01 | MRNA | Mock James M | CFO | F - Tax | $140.34 | -1,197 | 68.3K | -2% | -$168.0K |
| D | 2026-09-03 16:52 | 2026-09-01 | MRNA | Mock James M | CFO | M - OptEx | $0.00 | -2,475 | 24.8K | -9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-01 | M | A | 2,475 | — | 69,479 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2026-09-01 | F | D | 1,197 | $140.34 | 68,282 | D | — | — | (F2) Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. |
| 3 | Derivative | Restricted Stock Units | 2026-09-01 | M | D | 2,475 | $0.00 | 24,755 | D | — · — to — | 2,475 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F1) Restricted stock units convert into common stock on a one-for-one basis. (F3) 25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. (F3) 25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |